MedTrace Logo

Radiation Dose Intensity Study in Breast Cancer in Young Women

NCT00212121 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2400

Last updated 2022-01-21

No results posted yet for this study

Summary

hypothesis: 10 Gy additional boost to the tumor bed will yield an increase in local control at 10 years from 88% to 93%, with still acceptable cosmesis.

Conditions

Interventions

RADIATION

high dose boost

high dose boost

PROCEDURE

boost

low dose versus high dose

Sponsors & Collaborators

  • UNICANCER

    collaborator OTHER

  • The Netherlands Cancer Institute

    lead OTHER

Principal Investigators

  • Liesbeth Boersma, MD · MAASTRO Clinic, Heerlen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • France
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00212121 on ClinicalTrials.gov